🌟 Ascimib 40 mg (Asciminib) – Everest Pharma

Ascimib 40 mg contains Asciminib, a novel, first-in-class STAMP (Specifically Targeting the ABL Myristoyl Pocket) inhibitor. It represents a breakthrough in the treatment of Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML), offering a highly selective mechanism of action for patients who are resistant or intolerant to prior tyrosine kinase inhibitors (TKIs).

💊 Composition

Each film-coated tablet contains:
👉 Asciminib 40 mg

⚡ Indications

Ascimib 40 mg is indicated for the treatment of:

• Adult patients with Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP),

• Who have been previously treated with two or more tyrosine kinase inhibitors (TKIs) or

• Who have the T315I mutation.

📌 Key Features

✅ First-in-class STAMP inhibitor (Specifically Targets ABL Myristoyl Pocket)
✅ Designed for highly selective targeting of BCR-ABL1
✅ Effective against resistant mutations, including T315I
✅ Oral therapy for convenient administration
✅ Manufactured by Everest Pharmaceuticals Ltd., committed to delivering innovative and affordable oncology treatments

🕒 Dosage & Administration

• Recommended dose: 40 mg twice daily for most Ph+ CML-CP patients without T315I mutation

• In patients with the T315I mutation: 200 mg twice daily (using appropriate tablet strength combinations)

• Should be taken without food (at least 2 hours after a meal and no food for at least 1 hour after taking the dose)

🏭 Manufacturer

Everest Pharmaceuticals Ltd.
A globally recognized pharmaceutical company focused on high-quality generic and novel oncology products.

📌 Category

➡️ Oncology / Anti-cancer Medicine
➡️ Targeted Therapy / Precision Medicine
➡️ STAMP Inhibitor / BCR-ABL Tyrosine Kinase Inhibitor Alternative

🧬 Therapeutic Class

• Specifically targeting BCR-ABL1 myristoyl pocket (STAMP inhibitor)

• Targeted agent for chronic myeloid leukemia (CML)

🚀 Why Choose Ascimib?

Ascimib 40 mg (Asciminib) provides a novel option for patients with chronic myeloid leukemia who have limited alternatives due to resistance or intolerance to existing TKIs. Its innovative STAMP mechanism offers precision targeting with a unique binding approach, making it an important tool in modern leukemia management.

🔹 Branding & Contact Information

Below the product box image, the branding for NP MOLECULE is clearly displayed:

·         A logo depicting a laboratory flask with a stylized DNA strand inside, symbolizing scientific advancement and precision medicine.

·         Contact details:
📞 +8801844288466
📧 npmolecule23@gmail.com
🌐 www.npmoleculeoncology.com
📍 Sector 14, Uttara, Dhaka-1230

·         QR Codes: Two QR codes are provided on either side of the contact details, labeled “Scan the QR code” for quick access to more information or digital contact.